Back to Authors

Matthews, Marc R

0000-0001-8885-3697

Mayo Clinic

Department of Family Medicine, Mayo Clinic, Rochester, MN, USA.

Citations 14

Impact of Symptom Remission on Outpatient Visits in Depressed Primary Care Patients Treated with Collaborative Care Management and Usual Care
Meunier, Matthew R. , Angstman, Kurt B. , MacLaughlin, Kathy L. , Oberhelman, Sara S. , Rohrer, James E. , Katzelnick, David J., Matthews, Marc R. , Matthews, Marc R

Population Health Management | February 4, 2014 | Volume: 17 | Issue: 3 | Pages: 180-184

10.1089/pop.2013.0057 Get It

Depression symptoms contribute to significant morbidity and health care utilization. The aim of this study was to determine the impact of symptom improvement (to remission) on outpatient clinical visits by depressed primary care patients. This study was a retrospective chart review analysis of 1733 primary care patients enrolled into collaborative care management (CCM) or usual care (UC) with 6-month follow-up data. Baseline data (including demographic information, clinical diagnosis, and depression severity) and 6-month follow-up data (Patient Health Questionnaire scores and the number of outpatient visits utilized) were included in the data set. To control for individual patient complexity and pattern of usage, the number of outpatient visits for 6 months prior to enrollment also was measured as was the presence of medical comorbidities. Multiple logistic regression analysis demonstrated that clinical remission at 6 months was an independent predictor of outpatient visit outlier status (>8 visits) (odds ratio [OR] 0.609, confidence interval (CI) 0.460–0.805, P <0.01) when controlling for all other independent variables including enrollment into CCM or UC. The OR of those patients not in remission at 6 months having outpatient visit outlier status was the inverse of this at 1.643 (CI 1.243–2.173). The most predictive variable for determining increased outpatient visit counts after diagnosis of depression was increased outpatient visits prior to diagnosis (OR 4.892, CI 3.655–6.548, P <0.01). In primary care patients treated for depression, successful treatment to remission at 6 months decreased the likelihood of the patient having more than 8 visits during the 6 months after diagnosis. ( Population Health Management 2014;17:180–184)
Prolonged Care Management for Depression
Angstman, Kurt B. , Pecina, Jennifer L. , Bernard, Matthew , Matthews, Marc R. , Pecina, Jennifer , Matthews, Marc R

Journal of Primary Care & Community Health | January 30, 2013 | Volume: 4 | Issue: 2 | Pages: 129-134

10.1177/2150131913475667 Get It

Introduction: Collaborative care management (CCM) for the treatment of depression has been shown to be an effective therapy. CCM can be seen as a resource intensive treatment. Early identification of patients who would not be effectively treated with CCM could allow for alteration of therapy or change in modality. Methods: A retrospective case-controlled study used 132 patients with prolonged enrollment (>1 year) in CCM (cases) and 396 randomized CCM patients who achieved remission within 6 months (controls). The hypothesis was that by studying the epidemiology of patients in prolonged care management (PCM), characteristics could be determined to help define this group. Results: With regression modeling, the odds of a patient having PCM at 1 year was highly significant for those unmarried patients (odds ratio [OR] = 1.736, confidence interval [CI] = 1.115-2.703, P = .015) with dysthymia (OR = 2.362, CI = 1.104-5.052, P = .027) and severe depression (OR = 2.856, CI = 1.551-5.260, P = .001). The adjusted baseline Patient Health Questionnaire–9 (PHQ-9) score showed a difference of 16.0 for the cases versus 14.8 for the controls ( P < .001). By 10 weeks, the difference is much larger at (10.7 vs 4.9, P < .001). At 26 weeks, the control group had an adjusted average PHQ-9 score of 2.0, whereas the case group was still elevated at 10.2 ( P < .001). Conclusions: Case-controlled analysis of PCM patients demonstrated independent predictors (such as unmarried status, diagnosis of dysthymia or severe depression), however, no baseline data was of sufficient clarity to suggest changes in clinical practice. The trend of the patient’s PHQ-9 over time was strongly suggestive of allowing differentiation between the groups.
Urinary fluticasone propionate-17beta-carboxylic acid to assess asthma therapy adherence
Hagan, John B., Netzel, Brian C., Matthews, Marc R. , Korpi‐Steiner, Nichole , Matthews, Marc R. , Singh, Ravinder , Matthews, Marc R

Allergy and Asthma Proceedings | July 25, 2012 | Volume: 33 | Issue: 4 | Pages: 35-39

10.2500/aap.2012.33.3568 Get It